miR-424-5p Regulates Stem-like and Malignant Phenotypes in Osteosarcoma by Targeting FZD4
TL;DR
Investigation of the role of frizzled class receptor 4 in OS progression found that it is highly expressed in OS and is associated with poor prognosis, and miR-424-5p can regulate these tumor-promoting effects by targeting FZD4.
Abstract
Simple Summary Osteosarcoma (OS) is an aggressive bone cancer with high diversity among tumor cells and poor outcomes for many patients. The factors that drive tumor growth, spread, and treatment resistance must be better understood to identify new biomarkers and therapeutic targets. In this study, the authors investigated the role of frizzled class receptor 4 in OS progression, especially its relationship with cancer cell stem-like properties and migration. Using single-cell analysis, clinical samples, and laboratory experiments, they found that frizzled class receptor 4 (FZD4) is highly expressed in OS and is associated with poor prognosis. Reducing its expression weakened the stem-like characteristics and migration ability of OS cells. This study also shows that miR-424-5p can regulate these tumor-promoting effects by targeting FZD4. These findings may help researchers develop new strategies for predicting prognosis and treating OS.